Benzodiazepine interruption: Does it cause hypoglycemia? [15]

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 2099-

  Wagner, Ana M ^a   Webb, Susan M ^a   Corcoy, Rosa ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CLONAZEPAM;

ADULT; CASE REPORT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPOGLYCEMIA; HYPOPHYSIS ADENOMA; INSULIN TREATMENT; LETTER; MALE;

EID: 0343953469     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.2099b     Document Type: Letter

References (6)

1. Najim RA, Al-Essa LY, Al-Jawad FH: Effects of some drugs acting at the central-type benzodiazepine receptors on blood glucose in mice. Clin Exp Pharmacol Physiol 16:7-12, 1989
2. Männistö PT, Laakso ML, Jarvinen A, Rago L: Effects of central and peripheral type benzodiazepine ligands on growth hormone and gonadotropin secretion in male rats. Pharmacol Toxicol 71:75-80, 1992
3. Black KL, Shiraishi T, Ikezak K, Tabuchi K, Becker D: Peripheral benzodiazepine stimulates secretion of growth hormone and mitochondrial proliferation in pituitary tumour GH3 cells. Neurol Res 16:74-80, 1994
4. Kannan V: Diazepam test of growth hormone secretion. Horm Metab Res 13:390-393, 1981
5. Zaccaria M, Giordano G, Ragazzi E, Sicolo N, Foresta C, Scandellari C: Lack of effect of im diazepam administration on hGH and hPRL in normal and acromegalic subjects. J Endocrinol Invest 8:167-170, 1985
6. Fanghanel G, Larraza O, Villalobos M, Fanghanel L, Velasco M, Velasco F: Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas. Can J Neurol Sci 17:78-82, 1990